Bionomics(澳大利亞)

Bionomics

澳大利亞Bionomicswww.bionomics.com.au是一個(gè)生產(chǎn)的藥物發(fā)現(xiàn)和開(kāi)發(fā)新的治療癌癥和嚴(yán)重的疾病，中樞神經(jīng)系統(tǒng)（CNS）通過(guò)應(yīng)用其專(zhuān)有技術(shù)平臺(tái)MultiCore®,Angene®andionX®,多個(gè)候選藥物和癌癥，焦慮癥，多發(fā)性硬化癥和癲癇治療領(lǐng)域的目標(biāo)。Bionomicsisaproductivedrugdiscoveryanddevelopment engineroomfocusedonnewtreatmentsforcancerandseriousdisordersofthecentralnervoussystem(CNS).Throughapplicationofitsproprietarytechnologyplatforms,MultiCore®,Angene®andionX®,BionomicshasgeneratedmultipledrugcandidatesandtargetsinthetherapeuticareasofCancer,Anxiety,MultipleSclerosisandEpilepsy.Thecompanyhasastrongout-licenserecordinconjunctionwithitsin-housedevelopmentprogramwhichhasseentwohighlypromisingdrugsenterclinicaltrialsinthepasttwoyears.BackgroundBionomicswasfoundedin1999byagroupofAustralia'sleadinghealthcareresearchersandinitiallyestablishedtechnologyplatformsinthegenomicsofepilepsy,angiogenesisandbreastcancer.